IL6 and neoplasm: iTAMs are further hallmarked by the expression of CD86high, CD206low, Cd163high, Hmox1high, show a pro-inflammatory phenotype associated with the production of ROS and pro-inflammatory cytokines (TNFα and IL-6), and are capable of killing tumor cells (Figures 7B–C).